ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 81.67 USD 0.41% Market Closed
Market Cap: 1.8B USD

Wall Street
Price Targets

ANIP Price Targets Summary
ANI Pharmaceuticals Inc

Wall Street analysts forecast ANIP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANIP is 111.33 USD with a low forecast of 90.9 USD and a high forecast of 127.05 USD.

Lowest
Price Target
90.9 USD
11% Upside
Average
Price Target
111.33 USD
36% Upside
Highest
Price Target
127.05 USD
56% Upside
ANI Pharmaceuticals Inc Competitors:
Price Targets
PBH
Prestige Consumer Healthcare Inc
32% Upside
GLAND
Gland Pharma Ltd
22% Upside
PHO
Photocure ASA
24% Upside
NEU
Neuren Pharmaceuticals Ltd
27% Upside
ARVN
Arvinas Inc
0% Downside
MARI
Marinomed Biotech AG
24% Upside
ETON
Eton Pharmaceuticals Inc
87% Upside

Revenue
Forecast

Revenue Estimate
ANI Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 76%. The projected CAGR for the next 3 years is 20%.

76%
Past Growth
20%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
ANI Pharmaceuticals Inc

The compound annual growth rate of ANI Pharmaceuticals Inc's operating income for the next 3 years is 379%.

N/A
Past Growth
379%
Estimated Growth
Estimates Accuracy
-62%
Average Miss

Net Income
Forecast

Net Income Estimate
ANI Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANIP's stock price target?
Price Target
111.33 USD

According to Wall Street analysts, the average 1-year price target for ANIP is 111.33 USD with a low forecast of 90.9 USD and a high forecast of 127.05 USD.

What is ANI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
20%

For the last 13 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 76%. The projected CAGR for the next 3 years is 20%.

What is ANI Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
379%

The compound annual growth rate of ANI Pharmaceuticals Inc's operating income for the next 3 years is 379%.

Back to Top